Company / Net Debt per Share
MADRIGAL PHARMACEUTICALS, INC. Net Debt per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$6.42
FY2025
5-year range
-$16.47 / $6.42
FY2021-FY2025
Trend
+626.6%
vs FY2024
Sector context
#26 of 82
Health Care
What the data says
Net Debt per Share changed +627% YoY in FY2025, a notable deviation from the 4-year average annual change of +33%.
Based on SEC 10-K filings.
6.42 in FY2025.
Increased from $0.86 to $6.42 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#57 of 82 in Health CareTop 68% of 82This company $6.42 Sector average $13.70
▼
-53.2% below sector average
Key checks
Key Insights
- MADRIGAL PHARMACEUTICALS, INC.'s net debt per share has grown for 3 consecutive years.
- In FY2025, net debt per share increased 626.6% year-over-year.
- Ranks #26 out of 82 companies in the Health Care sector.
- Lowest net debt per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.42 | +626.6% |
| FY2024 | $0.88 | +2.7% |
| FY2023 | $0.86 | +105.2% |
| FY2022 | -$16.47 | -604.3% |
| FY2021 | -$2.34 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026